• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红色素通过调节肠道微生物群和代谢产物减轻高脂高糖饮食诱导的小鼠非酒精性脂肪性肝病。

red pigments alleviate high-fat and high-sugar diet-induced NAFLD in mice by modulating the gut microbiota and metabolites.

作者信息

Gao Wenyan, Chen Xinghao, Wu Shaokang, Jin Lu, Chen Xu, Mao Genxiang, Wan Xiaoqing, Xing Wenmin

机构信息

School of Pharmacy Hangzhou Medical College Hangzhou China.

Department of Pharmacy Qingdao Sixth People's Hospital Qingdao China.

出版信息

Food Sci Nutr. 2024 May 21;12(8):5762-5775. doi: 10.1002/fsn3.4208. eCollection 2024 Aug.

DOI:10.1002/fsn3.4208
PMID:39139961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11317676/
Abstract

red pigments (MRP) may have benefits against NAFLD with an unclear mechanism. This study aimed to explore the protective effect of MRP supplementation against NAFLD through regulation of gut microbiota and metabolites. The C57BL/6 mice animals were randomly allocated into the normal diet (NC), HFHS diet-induced NAFLD model, and MRP intervention group fed with HFHS diet. Serum lipid profiles and liver function parameters were measured. Liver and colon histopathology analysis was conducted to determine the injury in the liver and colon. 16S rRNA gene sequencing was employed to analyze gut microbial composition from fecal samples. Untargeted metabonomics was performed to analyze changes in metabolites in serum and fecal samples. MRP supplementation significantly improved the HFHS-induced alterations in body weight, lipid profiles, and liver function ( < .01). MRP supplementation decreased the abundance of , , , and , while increasing , , and in mice fed the HFHS diet. Furthermore, MRP supplementation improved the serum and fecal metabolic profiles induced by the HFHS diet, primarily involving the arachidonic acid metabolism, unsaturated fatty acid biosynthesis, and adipocyte lipolysis pathways. Liver function and lipid profiles were closely associated with the abundance of , , , , and ( < .01). These findings revealed that MRP supplementation may help restore gut microbiota composition and balance its metabolites, thereby improving NAFLD. This study presents a novel outlook on the potential benefits of MRP supplementation in ameliorating NAFLD and supports the application of MRP as a new functional food.

摘要

红色色素(MRP)可能对非酒精性脂肪性肝病(NAFLD)有益,但其机制尚不清楚。本研究旨在通过调节肠道微生物群和代谢产物来探讨补充MRP对NAFLD的保护作用。将C57BL/6小鼠随机分为正常饮食组(NC)、高脂高糖饮食诱导的NAFLD模型组和喂食高脂高糖饮食的MRP干预组。检测血清脂质谱和肝功能参数。进行肝脏和结肠组织病理学分析以确定肝脏和结肠的损伤。采用16S rRNA基因测序分析粪便样本中的肠道微生物组成。进行非靶向代谢组学分析血清和粪便样本中代谢产物的变化。补充MRP显著改善了高脂高糖饮食诱导的体重、脂质谱和肝功能变化(P<0.01)。补充MRP降低了喂食高脂高糖饮食小鼠中[具体细菌名称未给出]、[具体细菌名称未给出]、[具体细菌名称未给出]和[具体细菌名称未给出]的丰度,同时增加了[具体细菌名称未给出]、[具体细菌名称未给出]和[具体细菌名称未给出]的丰度。此外,补充MRP改善了高脂高糖饮食诱导的血清和粪便代谢谱,主要涉及花生四烯酸代谢、不饱和脂肪酸生物合成和脂肪细胞脂解途径。肝功能和脂质谱与[具体细菌名称未给出]、[具体细菌名称未给出]、[具体细菌名称未给出]、[具体细菌名称未给出]和[具体细菌名称未给出]的丰度密切相关(P<0.01)。这些发现表明,补充MRP可能有助于恢复肠道微生物群组成并平衡其代谢产物,从而改善NAFLD。本研究为补充MRP在改善NAFLD方面的潜在益处提供了新的见解,并支持将MRP作为一种新型功能性食品应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/5f6302c75c54/FSN3-12-5762-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/b7cd38232c6b/FSN3-12-5762-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/4ee87851fed1/FSN3-12-5762-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/fe91ea58b056/FSN3-12-5762-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/93580d07feb8/FSN3-12-5762-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/0c4d34dd1e61/FSN3-12-5762-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/2e27ea7b3818/FSN3-12-5762-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/5f6302c75c54/FSN3-12-5762-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/b7cd38232c6b/FSN3-12-5762-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/4ee87851fed1/FSN3-12-5762-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/fe91ea58b056/FSN3-12-5762-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/93580d07feb8/FSN3-12-5762-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/0c4d34dd1e61/FSN3-12-5762-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/2e27ea7b3818/FSN3-12-5762-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8559/11317676/5f6302c75c54/FSN3-12-5762-g001.jpg

相似文献

1
red pigments alleviate high-fat and high-sugar diet-induced NAFLD in mice by modulating the gut microbiota and metabolites.红色素通过调节肠道微生物群和代谢产物减轻高脂高糖饮食诱导的小鼠非酒精性脂肪性肝病。
Food Sci Nutr. 2024 May 21;12(8):5762-5775. doi: 10.1002/fsn3.4208. eCollection 2024 Aug.
2
Monascus yellow, red and orange pigments from red yeast rice ameliorate lipid metabolic disorders and gut microbiota dysbiosis in Wistar rats fed on a high-fat diet.红曲米中的红曲菌黄色素、红色素和橙色素可改善高脂饮食喂养的 Wistar 大鼠的脂代谢紊乱和肠道菌群失调。
Food Funct. 2019 Feb 20;10(2):1073-1084. doi: 10.1039/c8fo02192a.
3
Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.四妙方通过调节肝脏脂质代谢和肠道微生物群来减轻非酒精性脂肪性肝病。
Phytomedicine. 2021 May;85:153544. doi: 10.1016/j.phymed.2021.153544. Epub 2021 Mar 10.
4
A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.一种源自白芍和甘草的植物性膳食补充剂通过调节肠道微生物群和减轻炎症来减轻非酒精性脂肪性肝病。
Phytomedicine. 2021 Oct;91:153693. doi: 10.1016/j.phymed.2021.153693. Epub 2021 Jul 30.
5
Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism.二陈汤通过重塑肠道菌群和调节血清代谢减轻高脂饮食诱导的大鼠非酒精性脂肪性肝病
Evid Based Complement Alternat Med. 2022 Mar 31;2022:6221340. doi: 10.1155/2022/6221340. eCollection 2022.
6
Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.糖肾方通过靶向肠道微生物群治疗 HFD 小鼠非酒精性脂肪肝病:16S rRNA 和非靶向代谢组学分析。
Biomed Pharmacother. 2024 Apr;173:116405. doi: 10.1016/j.biopha.2024.116405. Epub 2024 Mar 14.
7
aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota.通过调节脂质代谢和重塑肠道微生物群加重高脂肪饮食诱导的非酒精性脂肪肝疾病。
Microbiol Spectr. 2024 Apr 2;12(4):e0339323. doi: 10.1128/spectrum.03393-23. Epub 2024 Feb 27.
8
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.用白藜芦醇靶向肠道微生物群:管理肝脂肪变性的新证据的例证。
J Nutr Biochem. 2020 Jul;81:108363. doi: 10.1016/j.jnutbio.2020.108363. Epub 2020 Feb 27.
9
Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism.大柴胡汤通过重塑肠道菌群和调节血清代谢改善高脂饮食诱导的非酒精性脂肪性肝病。
Front Pharmacol. 2020 Nov 27;11:584090. doi: 10.3389/fphar.2020.584090. eCollection 2020.
10
Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice.单独补充水飞蓟素或与丹酚酸B和葛根素联合补充可调节肠道微生物群及其代谢,以改善高脂饮食诱导的小鼠非酒精性脂肪性肝病。
Nutrients. 2024 Apr 14;16(8):1169. doi: 10.3390/nu16081169.

引用本文的文献

1
The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies.微生物群-肠-脑轴与中枢神经系统疾病:从发病机制到治疗策略
Front Microbiol. 2025 Jun 13;16:1583562. doi: 10.3389/fmicb.2025.1583562. eCollection 2025.

本文引用的文献

1
Plasma phospholipid arachidonic acid in relation to non-alcoholic fatty liver disease: Mendelian randomization study.血浆磷脂花生四烯酸与非酒精性脂肪性肝病的关系:孟德尔随机化研究
Nutrition. 2023 Feb;106:111910. doi: 10.1016/j.nut.2022.111910. Epub 2022 Nov 6.
2
Monascuspiloin from -Fermented Red Mold Rice Alleviates Alcoholic Liver Injury and Modulates Intestinal Microbiota.来源于红曲发酵米的红曲菌红素减轻酒精性肝损伤并调节肠道微生物群。
Foods. 2022 Sep 30;11(19):3048. doi: 10.3390/foods11193048.
3
Human gut microbiota in health and disease: Unveiling the relationship.
健康与疾病中的人类肠道微生物群:揭示其关系。
Front Microbiol. 2022 Sep 26;13:999001. doi: 10.3389/fmicb.2022.999001. eCollection 2022.
4
Antioxidative, anti-inflammatory, and anticancer properties of the red biopigment extract from Monascus purpureus (MTCC 369).紫红曲霉(MTCC 369)红色生物色素提取物的抗氧化、抗炎和抗癌特性。
J Food Biochem. 2022 Sep;46(9):e14249. doi: 10.1111/jfbc.14249. Epub 2022 May 26.
5
A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease.一项针对非酒精性脂肪性肝病患者的微生物组网络对运动和饮食干预反应的随机对照试验。
Nat Commun. 2022 May 10;13(1):2555. doi: 10.1038/s41467-022-29968-0.
6
Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.非酒精性脂肪性肝病与肠-肝轴:从营养不良角度进行探索
Gastroenterology. 2022 Jun;162(7):1858-1875.e2. doi: 10.1053/j.gastro.2022.01.058. Epub 2022 Mar 3.
7
Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis.多组学分析揭示了微生物群对肝脂肪变性中宿主代谢的影响。
Adv Sci (Weinh). 2022 Apr;9(11):e2104373. doi: 10.1002/advs.202104373. Epub 2022 Feb 7.
8
The cytotoxicity of cyclophosphamide is enhanced in combination with monascus pigment.环磷酰胺与红曲色素联合使用时细胞毒性增强。
J Clin Biochem Nutr. 2021 Sep;69(2):131-136. doi: 10.3164/jcbn.20-197. Epub 2021 Apr 7.
9
Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease.2型糖尿病和非酒精性脂肪性肝病中的肠-肝相互作用
Metabolism. 2021 Oct;123:154844. doi: 10.1016/j.metabol.2021.154844. Epub 2021 Aug 1.
10
Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet.紫红红曲菌SHM1105发酵的红曲米和红曲色素对高脂饮食大鼠肠道微生物群和肝脏转录组的调节作用
Front Pharmacol. 2021 Jan 21;11:599760. doi: 10.3389/fphar.2020.599760. eCollection 2020.